Status:
COMPLETED
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Liver Regeneration
Ursodeoxycholic Acid
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The goal of this open label randomized trial is to understand the role of oral ursodeoxycholic acid(UDCA) supplementation in the liver regeneration (in terms of liver function and anatomical growth) f...
Detailed Description
This open label randomized control study aims to analyze the effect of ursodeoxycholic acid supplementation on liver regeneration following a right donor hepatectomy. All eligible live donors who unde...
Eligibility Criteria
Inclusion
- All live donors undergoing Right Donor Hepatectomy in ILBS from ethical board clearance to December 2024 in the Department of HPB Surgery and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi
Exclusion
- Negative consent
- Hypersensitivity to UDCA
- Past history of UDCA use in the last two weeks
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06091787
Start Date
September 1 2023
End Date
November 30 2024
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver and Biliary Sciences
New Delhi, India, 110070